Article
Function of the SOS process in repair of DNA damage induced by modern 4-quinolones.
The Journal of pharmacy and pharmacology - 1 Jul 1993
Howard B M, Pinney R J, Smith J T
Abstract excerpt
The recA13 mutant of Escherichia coli strain K-12, which lacks recombination and SOS error-prone DNA repair is hypersensitive to nalidixic acid and to the newer 4-quinolones ciprofloxacin, norfloxacin and ofloxacin. However, whereas recombination-proficient but SOS repair-deficient strains, such...
Topics
- Anti-Infective Agents
- Cell Division
- Ciprofloxacin
- DNA Damage
- DNA Repair
- DNA, Bacterial
- Escherichia coli
- Mutation
- Nalidixic Acid
- Norfloxacin
- Ofloxacin
- RNA, Bacterial
- SOS Response, Genetics
